Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?

about

Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?

Item

http://www.wikidata.org/entity/Q38622918

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Are there any new insights for ...... of haematological malignants?

@en

type

Item

label

Are there any new insights for ...... of haematological malignants?

@en

prefLabel

Are there any new insights for ...... of haematological malignants?

@en

P1476

Are there any new insights for ...... of haematological malignants?

@en

P2093

Cheng Zhang

http://www.w3.org/2001/XMLSchema#string

Dong-Feng Zeng

http://www.w3.org/2001/XMLSchema#string

Pei-Yan Kong

http://www.w3.org/2001/XMLSchema#string

Xi Zhang

http://www.w3.org/2001/XMLSchema#string

Ying-Ying Ma

http://www.w3.org/2001/XMLSchema#string

Zhao-Hua Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche.

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches.

P2888

s12032-015-0705-9

P304

262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-015-0705-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042893151

http://www.w3.org/2001/XMLSchema#string

P698

26526720

http://www.w3.org/2001/XMLSchema#string